Comparing Interventions for Indoor Air -Related Functional Symptoms (TOSI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02069002|
Recruitment Status : Completed
First Posted : February 21, 2014
Last Update Posted : August 7, 2018
|Condition or disease||Intervention/treatment||Phase|
|Environmental Illness Functional Symptoms||Behavioral: Cognitive-Behavioral Therapy (CBT) Behavioral: Applied relaxation group therapy Behavioral: Information session (psychoeducation)||Not Applicable|
Indoor air -related respiratory and other multiple organ symptoms are common in work environments in Finland. Symptoms effect on well-being and quality of life and may lead to impaired social and cognitive functioning and decreased work ability. All indoor air -related conditions are not explained by underlying physical factors and remain medically unexplained. Functional disorders are conditions where patients complain of multiple medically unexplained physical symptoms or physical problems don´t correlate with symptom severity. Indoor air -related symptoms and functional disorders are strongly associated to each other but there are no well-established diagnostic criteria for the condition . So far, there is no available treatment program to the indoor air -related symptoms to offer in primary or occupational health care services in Finland.
In randomized controlled trials, cognitive behavioral treatment has shown to be effective for patients suffering from functional disorders. In addition, a relaxation technique entitled as applied relaxation (Tuomisto & al, 1996) have shown to been shown to been effective to treat different kind of functional problems.
There are no published trials on treatment for individuals of indoor air related symptomatology. The present study is designed as a pragmatic trial to investigate the effect of three different treatment programs as compared to treatment as usual (TAU) for indoor air- related problems in order to improve the (1) work capacity and (2) well-being. A secondary aim of the study is to identify psychological factors affecting the patients' response to the treatment.
The patients are recruited from occupational health care services to establish and to evaluate the efficacy and usability of the treatment procedures. Participants will first undergo baseline assessment including medical examination of the respiratory symptoms. Then they are randomized to one of the study groups: TAU or one of the intervention groups. All study patients receive TAU at occupational health care services for their medical problems during the study. Patients randomized to the study groups receive also the intervention with TAU.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||75 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Psychosocial Interventions for Indoor Air -Related Functional Symptoms - Randomized Controlled Trial (RCT)|
|Actual Study Start Date :||February 2014|
|Actual Primary Completion Date :||July 29, 2018|
|Actual Study Completion Date :||July 30, 2018|
Experimental: Cognitive-Behavioral Therapy (CBT)
There will be ten (10) manualized session, fist 90 minutes and nine (9) 45-minute individual sessions conducted at weekly intervals, last two sessions 2 weeks intervals. One booster session will be conducted three months after the treatment. Sessions include psychoeducation about indoor air related symptoms and personal health behavior factors integrated on patients individual symptomatology, cognitive restructuring, behavioral experiments of patients health promoting behavior, imagery rescripting and relapse prevention.
Intervention: Behavioral: Psychotherapy (CBT)
Behavioral: Cognitive-Behavioral Therapy (CBT)
Experimental: Applied relaxation group therapy
There will be seven (7) manualized session, first 120 minutes and six (6) 90-minute group sessions conducted at weekly intervals, last two sessions 2 weeks intervals. One booster session will be conducted three months after treatment. Sessions include information about indoor air related symptoms, behavioral training and experiments focusing on applied relaxation technique and relapse prevention.
Intervention: Behavioral: group therapy (ART)
NB: The Applied Relaxation group Therapy won´t be carried out due to slow and prolonged recruiting process (A steering group agreement 4/2015 and the Ethics Committee approval 5/2015 for the change of the study plan).
Behavioral: Applied relaxation group therapy
Experimental: Information session (psychoeducation)
There will be one (1) manualized 90-minute individual session. The session includes information about indoor air related symptoms and factors affecting individual health behavior.
Intervention: Information session (psychoeducation)
Behavioral: Information session (psychoeducation)
- 15D - instrument [ Time Frame: baseline, 3, 6 and 12 months from the baseline ]The health-related quality of life (HRQoL) instrument (Sintonen, 2001)
- • Generalized Anxiety Disorder (GAD-7) [ Time Frame: baseline, 3, 6 and 12 months from the baseline ]Self-report measure that assesses anxiety symptoms
- Insomnia Severity Index (ISI) [ Time Frame: baseline, 3, 6 and 12 months from the baseline ]Self-report measure that assesses insomnia severity
- The Symptom checkList-90 (SCL-90) [ Time Frame: baseline, 6 and 12 months from the baseline ]Self-report measure that assesses general psychological and somatic symptoms and severity
- The Patient Health Questionnaire (PHQ-9) [ Time Frame: baseline, 3, 6 and 12 months from the baseline ]Self-report measure that assesses depressive symptoms
- Visual Analogue Scale (VAS) [ Time Frame: baseline, 3, 6 and 12 months from the baseline ]Self-report measure that assesses respiratory symptom severity
- The Acceptance and Action Questionnaire-2 (AAQ-2) [ Time Frame: baseline, 3, 6 and 12 months from the baseline ]Self-report measure focuses on experiential avoidance and psychological inflexibility
- Illness Worry Scale (IWS) [ Time Frame: baseline, 3, 6 and 12 months from the baseline ]Self-report measure that focuses on illness worries and attitudes towards illness
- Penn State Worry Questionnaire (PSWQ) [ Time Frame: baseline, 3, 6 and 12 months from the baseline ]Self-report measure that focuses on mourning and continuous worrying toughs
- Need for Recovery (NRF) [ Time Frame: baseline, 3, 6 and 12 months from the baseline ]Self-report measure that focuses on time needed on the recovery after work day
- Strategy and Attribution Questionnaire (SAQ) [ Time Frame: baseline, 6 and 12 months from the baseline ]Self-report measure focuses on personal attribute strategies.
- Self-assessed work ability [ Time Frame: baseline, 3, 6 and 12 months from the baseline ]Self-assessed work ability (on a scale 0-10) (Tuomi & al. 1998)
- Working Alliance Inventory (WAI) [ Time Frame: after the first, fifth and the last session of the CBT ]Self-report measure that assesses three key aspects of the therapeutic alliance: (a) agreement on the tasks of therapy, (b) agreement on the goals of therapy and (c) development of an affective bond; for therapists and the patient of the individual cognitive-behavior therapy
- Sense of coherence Group (SOC-G-20) [ Time Frame: after the first, fourth and the last session of the grouptherapy ]For the group therapy patients to evaluate the groups therapeutic alliance.
- Satisfaction of the treatment [ Time Frame: 3, 6 and 12 months from the baseline ]Questionnaire for the intervention groups patients to evaluate the satisfaction of the treatment and its efficacy.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02069002
|Finnish Institute of Occupational Health (Finland)|
|Helsinki, Uusimaa, Finland, 00250|
|Principal Investigator:||Tiina M. Paunio, MD, PhD||Finnish Institute of Occupational Health and University of Helsinki|